ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
Heliostar Metals to Present at the Precious Metals & Critical Minerals Virtual Investor Conference October 14
